SLN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Silence Therapeutics PLC

Watchlist Manager

Watchlist

Price: 11.22 USD -2.52% Market Closed

Market Cap: $523.5m

	Silence Therapeutics PLC NASDAQ:SLN	UK
	PainChek Ltd ASX:PCK	AU
	Viva Leisure Ltd ASX:VVA	AU
N	Nel ASA SWB:D7G	NO
S	SLB NV F:SCL	US
	Wing Tai Holdings Ltd SGX:W05	SG
	1RT Acquisition Corp NASDAQ:ONCH	US
	Technical Olympic SA F:TQZA	GR
	Community Healthcare Trust Inc F:4U9	US
C	Ciena Corp DUS:CIE1	US
	Tractor Supply Co NASDAQ:TSCO	US
T	Texas Instruments Inc F:TII	US

Profitability Summary

Silence Therapeutics PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

52% > 86%

Negative Operating Margin

-12 497%

Negative 3Y Average Operating Margin

-3 359%

Declining Operating Margin

-168% > -12 497%

Negative Net Margin

-11 139%

Negative 3Y Average Net Margin

-3 176%

Declining Net Margin

-145% > -11 139%

Exceptional Free Cash Flow Margin

2 019%

Strong 3Y Average Free Cash Flow Margin

509%

Free Cash Flow Margin is Increasing

43% > 2 019%

Negative ROE

-88%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-218%

ROIC is Increasing

-134% > -101%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.